WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 3:02 pm Sale | 2022-12-30 | 13G | Nektar Therapeutics NKTR | WELLINGTON MANAGEMENT CO LLP | 0 0.000% | -11,383,721 (Position Closed) | Filing |
| 2022-02-04 09:29 am Sale | 2021-12-31 | 13G | Nektar Therapeutics NKTR | WELLINGTON MANAGEMENT CO LLP | 11,383,721 6.170% | -2,008,891 (-15.00%) | Filing |
| 2021-02-04 11:31 am Sale | 2020-12-31 | 13G | Nektar Therapeutics NKTR | WELLINGTON MANAGEMENT CO LLP | 13,392,612 7.470% | -2,805,567 (-17.32%) | Filing |